alphaveMAKERSL₹177.20

Makers Laboratories Limited

₹ CrorePeersBPLPHARMA JENBURPH KPL NOVARTIND PARNAXLAB SGRL SHUKRAPHAR SUNLOC

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026
Non-current Assets
+ Property, Plant & Equipment	39.8	29.3	26.9
+ Capital Work-in-Progress	0.0	0.0	0.1
+ Other Intangibles	0.1	0.0	0.0
+ Non-current Investments	22.6	22.6	22.6
+ Other Non-current Assets	2.0	2.5	3.1
Current Assets
+ Inventories	11.0	7.8	10.6
+ Trade Receivables	6.6	5.3	6.0
+ Cash & Cash Equivalents	0.0	0.0	0.0
+ Other Bank Balances	0.0	0.0	0.0
+ Short-term Loans	0.0	0.0	0.0
+ Other Current Assets	2.4	2.3	3.0
Total Assets	86.1	71.4	73.5
Equity
+ Equity Share Capital	5.9	5.9	5.9
+ Other Equity / Reserves	45.5	50.2	48.5
Total Equity	51.4	56.1	54.4
Liabilities
+ Borrowings — Non-current	6.0	0.0	—
+ Other Non-current Financial Liab	1.0	0.0	0.0
+ Provisions — Non-current	0.2	0.2	0.3
+ Deferred Tax Liabilities	0.2	0.5	0.2
+ Borrowings — Current	7.6	0.3	2.7
+ Trade Payables	10.3	6.3	7.6
+ Other Current Financial Liab	4.4	3.7	3.7
+ Provisions — Current	1.2	1.1	0.9
+ Current Tax Liabilities	25.7	13.5	17.8
+ Other Current Liabilities	1.9	1.8	2.6
Total Equity & Liabilities	86.1	71.4	73.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.